Physician profile
Todd A Borus
NPI 1700858651
$357,167.37
in general payments reported to CMS, 2019-2025
10 companies · $30K in 2025
The $30K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134K · 2020: $49K · 2021: $20K · 2022: $30K · 2023: $40K · 2024: $54K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $95K · Travel and Lodging: $19K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,200 · Food and Beverage: $3,580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $94,725.00 |
| Travel and Lodging | $18,990.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,200.00 |
| Food and Beverage | $3,580.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $294,159.13 | 2019-2025 | Mako, Aequalis, Triathlon |
| Globus Medical, INC. | $31,433.05 | 2023-2025 | Excelsiusgps Robotic Navigation System, Onvoy, Legacy Stelkast Knee |
| Nextstep Arthropedix, LLC | $30,502.91 | 2019-2020 | |
| Depuy Synthes Sales INC. | $446.29 | 2019-2023 | Attune, Actis |
| Davol INC. | $298.14 | 2023 | Arista Ah Flexitip |
| Vertex Pharmaceuticals Incorporated | $125.00 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $116.95 | 2023 | Iovera |
| Avanos Medical | $49.50 | 2019 | |
| Zimmer Biomet Holdings, INC. | $36.40 | 2024 | Persona, Rosa |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$775,211.82 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Borus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.